The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women

AIDS

Volumn 18, Issue 7, 2004, Pages 1051-1059

  Mwapasa, Victor ^a,b   Rogerson, Stephen J ^c   Molyneux, Malcolm E ^a   Abrams, Elizabeth T ^b   Kamwendo, Deborah D ^b   Lema, Valentino M ^a   Tadesse, Eyob ^a   Chaluluka, Ebbie ^a   Wilson, Paul E ^d   Meshnick, Steven R ^d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d IL   (United States)

Author keywords

Africa; HIV 1; Malaria; Malawi; Pregnancy; Vertical transmission

Indexed keywords

CD4 ANTIGEN; NEVIRAPINE; VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; FEMALE; GEOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; INTRAUTERINE INFECTION; LABOR; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALAWI; MULTIVARIATE ANALYSIS; MULTIVARIATE ANALYSIS OF COVARIANCE; PLACENTA; PLACENTA CIRCULATION; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PRIORITY JOURNAL; RNA ANALYSIS; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALARIA, FALCIPARUM; PARASITEMIA; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, VIRAL; VIRAL LOAD;

EID: 2342520186     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200404300-00014     Document Type: Article

References (44)

1. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001, 64:28-35.
2. Quinn TC. Global burden of the HIV pandemic. Lancet 1996, 348:99-106.
3. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS 1998, 12:197-203.
4. Francesconi P, Fabiani M, Dente MG, Lukwiya M, Okwey R, Ouma J, et al. HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS 2001, 15:2445-2450.
5. Gregson S, Terceira N, Kakowa M, Mason PR, Anderson RM, Chandiwana SK, et al. Study of bias in antenatal clink HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS 2002, 16:643-652.
6. Fylkesnes K, Musonda RM, Sichone M, Ndhlovu Z, Tembo F, Monze M. Declining HIV prevalence and risk behaviours in Zambia: evidence from surveillance and population-based surveys. AIDS 2001, 15:907-916.
7. US Census Bureau. Estimates of HIV-1 and HIV-2 seroprevalence by residence and risk factor for developing countries: circa 2000. In: US Census Bureau 2003. Accessed 28 August 2003: http://www.census.gov/ipc/www/hiv3afri. html.
8. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999, 341:394-402.
9. Katzenstein DA, Mbizvo M, Zijenah L, Gittens T, Munjoma M, Hill D, et al. Serum level of maternal human immunodeficiency virus (HIV) RNA, infant mortality, and vertical transmission of HIV in Zimbabwe. J Infect Dis 1999, 179:1382-1387.
10. Mock PA, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS 1999, 13:407-414.
11. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:506-510.
12. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354:795-802.
13. O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000, 14:441-448.
14. European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. The European Collaborative Study. AIDS 1999, 13:1377-1385.
15. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996, 157:1271-1278.
16. Ostrowski MA, Krakauer DC, Li Y, Justement SJ, Learn G, Ehler LA, et al. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J Virol 1998, 72:7772-7784.
17. Bush CE, Donovan RM, Markowitz NP, Kvale P, Saravolatz LD. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:23-26.
18. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995, 182:1727-1737.
19. Marchisio P, Esposito S, Zanchetta N, Tornaghi R, Gismondo MR, Principi N. Effect of superimposed infections on viral replication in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 1998, 17:755-757.
20. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999, 13:487-494.
21. Kapiga SH, Bang H, Spiegelman D, Msamanga GI, Coley J, Hunter DJ, et al. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002, 30:316-323.
22. Desowitz RS, Alpers MP. Placental Plasmodium falciparum parasitaemia in East Sepik (Papua New Guinea) women of different parity: the apparent absence of acute effects on mother and foetus. Ann Trop Med Parasitol 1992, 86:95-102.
23. Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health 2001, 6:770-778.
24. Ordi J, Ismail MR, Ventura PJ, Kahigwa E, Hirt R, Cardesa A, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998, 22:1006-1011.
25. Bulmer JN, Rasheed FN, Morrison L, Francis N, Greenwood BM. Placental malaria. II. A semi-quantitative investigation of the pathological features. Histopathology 1993, 22:219-225.
26. Walter PR, Garin Y, Blot P. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol 1982, 109:330-342.
27. Tkachuk AN, Moormann AM, Poore JA, Rochford RA, Chensue SW, Mwapasa V, et al. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J Infect Dis 2001, 183:967-972.
28. Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 1998, 177:437-445.
29. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998, 160:2523-2530.
30. Moormann AM, Sullivan AD, Rochford RA, Chensue SW, Bock PJ, Nyirenda T, et al. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999, 180:1987-1993.
31. Fievet N, Moussa M, Tami G, Maubert B, Cot M, Deloron P, et al. Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta. J Infect Dis 2001, 183:1530-1534.
32. Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG, Molyneux ME. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 2000, 62:335-340.
33. Rogerson SJ PE, Getachew A, Tadesse E, Lema V, Molyneux ME. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg, 2003, 68:115-119.
34. Michael NL, Herman SA, Kwok S, Dreyer K, Wang J, Christopherson C, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved Amplicor HIV-1 Monitor test with isolates of diverse subtypes. J Clin Microbiol 1999, 37:2557-2563.
35. Brabin B. An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy. Int J Epidemiol 1991, 20:276-283.
36. Clark IA, al Yaman FM, Jacobson LS. The biological basis of malarial disease. Int J Parasitol 1997, 27:1237-1249.
37. Pichyangkul S, Saengkrai P, Webster HK. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. Am J Trop Med Hyg 1994, 51:430-435.
38. Currier J, Beck HP, Currie B, Good MF. Antigens released at schizont burst stimulate Plasmodium falciparum-specific CD4+ T cells from non-exposed donors: potential for cross-reactive memory T cells to cause disease. Int Immunol 1995, 7:821-833.
39. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989, 86:2336-2340.
40. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993, 5:165-173.
41. Rogerson SJ, Brown HC, Pollina E, Abrams ET, Tadesse E, Lema VM, et al. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun 2003, 71:267-270.
42. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998, 59:813-822.
43. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 1998, 92:141-150.
44. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995, 9:721-726